-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Viridian Therapeutics, Inc.\DE quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2020 to Q2 2024.
- Viridian Therapeutics, Inc.\DE Earnings Per Share, Basic for the quarter ending June 30, 2024 was -1.02 USD/shares, a 19.7% increase year-over-year.
- Viridian Therapeutics, Inc.\DE Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -4.24 USD/shares, a 13.3% increase year-over-year.
- Viridian Therapeutics, Inc.\DE annual Earnings Per Share, Basic for 2023 was -5.31 USD/shares, a 31.1% decline from 2022.
- Viridian Therapeutics, Inc.\DE annual Earnings Per Share, Basic for 2022 was -4.05 USD/shares, a 39.2% increase from 2021.
- Viridian Therapeutics, Inc.\DE annual Earnings Per Share, Basic for 2021 was -6.66 USD/shares, a 78.6% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)